Back to User profile » Dr Yonggui Wu
Papers published by Dr Yonggui Wu:
Development of a Diagnostic Model for Focal Segmental Glomerulosclerosis: Integrating Machine Learning on Activated Pathways and Clinical Validation
Ge Y, Liu X, Shu J, Jiang X, Wu Y
International Journal of General Medicine 2025, 18:1127-1142
Published Date: 26 February 2025
Integrated Analysis of Ferroptosis and Immunity-Related Genes Associated with Diabetic Kidney Disease
Wang J, Wang L, Pang Z, Ge Q, Wu Y, Qi X
Diabetes, Metabolic Syndrome and Obesity 2023, 16:3773-3793
Published Date: 23 November 2023
Clinical Significance of Glomerular Autophagy in Evaluation of Diabetic Kidney Disease Progression
Wang X, Zeng HX, Jiang L, Liu XQ, Huang YB, Wu YG
Diabetes, Metabolic Syndrome and Obesity 2022, 15:1945-1959
Published Date: 24 June 2022
Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K/Akt/NF-κB Signaling Pathways
Lei L, Zhao J, Liu XQ, Chen J, Qi XM, Xia LL, Wu YG
Drug Design, Development and Therapy 2021, 15:3131-3150
Published Date: 16 July 2021
Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-κB and TGF-β1/Smad3 Signaling Pathways in Diabetic Nephropathy
Zheng Z, Zhu W, Lei L, Liu X, Wu Y
Drug Design, Development and Therapy 2020, 14:4135-4148
Published Date: 8 October 2020
Paeoniflorin attenuates incipient diabetic nephropathy in streptozotocin-induced mice by the suppression of the Toll-like receptor-2 signaling pathway
Shao YX, Xu XX, Wang K, Qi XM, Wu YG
Drug Design, Development and Therapy 2017, 11:3221-3233
Published Date: 9 November 2017